Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Whether GLP-1 receptor agonists sequential therapy in newly diagnosed type 2 diabetic
patients can further improve glycemic control, diabetes remission rate and β-cell function
after the short-term insulin intensive therapy.
Phase:
Phase 4
Details
Lead Sponsor:
xiaolong zhao
Collaborators:
Fuling Central Hospital of Chongqing City Pudong Gongli hospital of Shanghai Second Affiliated Hospital of Soochow University Shanghai Pudong New Area Gongli Hospital Shanghai Zhongshan Hospital Taizhou Hospital The First Hospital of Guiyang Medical college The third people's Hospital Affiliated to Shanghai Jiao Tong University